the cardiovascular profile of aq-a 39 indicated that , especially for arterial plasma concentrations lower than 1500 ng . ml-1 , the drug may be useful in the treatment of tachycardias and in lowering myocardial o2-demand , without adverse effects on cardiovascular performance .
C0039231
tachycardias
C0007226
cardiovascular